A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala

We established a novel brain slice assay to test the ability of acetylcholinesterase (AChE) reactivators to prevent ACh-induced M1 muscarinic acetylcholine receptor (mAChR) dependent hyperexcitability observed after exposure to the organophosphate (OP)-based AChE inhibitor and sarin surrogate 4-nitr...

Full description

Bibliographic Details
Main Authors: Jeffrey S. Thinschmidt, Scott W. Harden, Michael A. King, James D. Talton, Charles J. Frazier
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2022.1066312/full
_version_ 1811319213794525184
author Jeffrey S. Thinschmidt
Scott W. Harden
Michael A. King
James D. Talton
Charles J. Frazier
author_facet Jeffrey S. Thinschmidt
Scott W. Harden
Michael A. King
James D. Talton
Charles J. Frazier
author_sort Jeffrey S. Thinschmidt
collection DOAJ
description We established a novel brain slice assay to test the ability of acetylcholinesterase (AChE) reactivators to prevent ACh-induced M1 muscarinic acetylcholine receptor (mAChR) dependent hyperexcitability observed after exposure to the organophosphate (OP)-based AChE inhibitor and sarin surrogate 4-nitrophenyl isopropyl methylphosphonate (NIMP). Whole-cell patch clamp recordings were used to evaluate the response of pyramidal neurons in the rat basolateral amygdala (BLA) to brief (1 min) bath application of ACh (100 μM), either in control conditions, or after exposure to NIMP ± an AChE reactivator. Bath application of ACh produced atropine- and pirenzepine-sensitive inward currents in voltage clamped BLA pyramidal neurons, and increased the frequency of spontaneous EPSCs, suggesting robust activation of M1 mAChRs. Responses to ACh were increased ~3–5 fold in slices that had been preincubated in NIMP, and these effects were reversed in a concentration dependent manner by exposure to a commercially available AChE reactivator. The current work outlines a simple assay that can be used to evaluate the efficacy of both known and novel AChE reactivators in an area of the limbic system that likely contributes to seizures after acute exposure to OP-based AChE inhibitors.
first_indexed 2024-04-13T12:37:54Z
format Article
id doaj.art-3545c7d60f87475388b0638bb2d7565a
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-13T12:37:54Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-3545c7d60f87475388b0638bb2d7565a2022-12-22T02:46:35ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022022-11-011610.3389/fncel.2022.10663121066312A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdalaJeffrey S. Thinschmidt0Scott W. Harden1Michael A. King2James D. Talton3Charles J. Frazier4Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, United StatesDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, United StatesAlchem Laboratories Corporation, Alachua, FL, United StatesAlchem Laboratories Corporation, Alachua, FL, United StatesDepartment of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, United StatesWe established a novel brain slice assay to test the ability of acetylcholinesterase (AChE) reactivators to prevent ACh-induced M1 muscarinic acetylcholine receptor (mAChR) dependent hyperexcitability observed after exposure to the organophosphate (OP)-based AChE inhibitor and sarin surrogate 4-nitrophenyl isopropyl methylphosphonate (NIMP). Whole-cell patch clamp recordings were used to evaluate the response of pyramidal neurons in the rat basolateral amygdala (BLA) to brief (1 min) bath application of ACh (100 μM), either in control conditions, or after exposure to NIMP ± an AChE reactivator. Bath application of ACh produced atropine- and pirenzepine-sensitive inward currents in voltage clamped BLA pyramidal neurons, and increased the frequency of spontaneous EPSCs, suggesting robust activation of M1 mAChRs. Responses to ACh were increased ~3–5 fold in slices that had been preincubated in NIMP, and these effects were reversed in a concentration dependent manner by exposure to a commercially available AChE reactivator. The current work outlines a simple assay that can be used to evaluate the efficacy of both known and novel AChE reactivators in an area of the limbic system that likely contributes to seizures after acute exposure to OP-based AChE inhibitors.https://www.frontiersin.org/articles/10.3389/fncel.2022.1066312/fullorganophosphatesbasolateral amygdalaacetylcholinesterasestatus epilepticusNIMPHI-6
spellingShingle Jeffrey S. Thinschmidt
Scott W. Harden
Michael A. King
James D. Talton
Charles J. Frazier
A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
Frontiers in Cellular Neuroscience
organophosphates
basolateral amygdala
acetylcholinesterase
status epilepticus
NIMP
HI-6
title A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
title_full A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
title_fullStr A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
title_full_unstemmed A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
title_short A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
title_sort rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala
topic organophosphates
basolateral amygdala
acetylcholinesterase
status epilepticus
NIMP
HI-6
url https://www.frontiersin.org/articles/10.3389/fncel.2022.1066312/full
work_keys_str_mv AT jeffreysthinschmidt arapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT scottwharden arapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT michaelaking arapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT jamesdtalton arapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT charlesjfrazier arapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT jeffreysthinschmidt rapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT scottwharden rapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT michaelaking rapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT jamesdtalton rapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala
AT charlesjfrazier rapidinvitroassayforevaluatingtheeffectsofacetylcholinesteraseinhibitorsandreactivatorsintheratbasolateralamygdala